UAB to study hand-held device that monitors traumatic brain injury – News

The device is a non-invasive scanner that uses near infrared light to assess brain damage.

The device is a non-invasive scanner that uses near infrared light to assess brain damage.Researchers at the University of Alabama at Birmingham will study the usefulness of a new, non-invasive method for measuring the expansion of hematomas in the brain. Expanding bruises – ruptures of blood vessels in the brain often caused by traumatic brain injury are associated with significantly worse outcomes for these patients.

Jan Jansen, MBBS, Ph.D., director of the UAB Center for Injury Science, and executive director Shannon Stephens, EMTP, will lead a $ 2.8 million two-year clinical trial to evaluate the device called Infrascanner. This project is funded by the Neurotrauma Program of the Combat Casualty Care Research Program at the U.S. Army Medical Research and Development Command through the Medical Technology Enterprise Consortium.

“We are delighted to be able to assess the role of this exciting new technology in detecting the expansion of hematomas,” said Jansen. “It may help improve the treatment of patients with traumatic brain injury and may improve outcomes.

The Infrascanner is a portable, non-invasive, FDA-approved device for detecting traumatic intracranial hematomas. The purpose of the trial is to assess the ability of the device to monitor the size of the hematomas and track any changes in size, as expanding hematomas often require a change in treatment.

The device uses near infrared spectroscopy to detect intracranial hematomas, based on the differential absorption of light associated with injured parts of the brain compared to uninjured parts.

Infrascanner The Infrascanner compares the left and right sides of the brain in four different areas. Measurements can be performed in a matter of minutes.

“The device allows a healthcare professional to detect and measure a hematoma quickly and easily, even in a harsh environment,” Jansen said. “Early detection is the key to minimizing brain damage and improving outcomes. “

The CIS Clinical Trials Unit will work with nine other Level I trauma centers across the country to recruit 400 trauma patients with intracranial hemorrhage.

Comments are closed.